Commure Raises $70 Million at $7 Billion Valuation

Healthcare AI company Commure has raised $70 million at a $7 billion post-money valuation in a round led by General Catalyst, with participation from Sequoia Capital, Morgan Stanley, and Kirkland & Ellis.

The financing suggests investors continue to see value in healthcare AI companies tied to operational and financial workflows rather than narrower experimental use cases.  

Commure’s platform is positioned across revenue cycle management, ambient documentation, practice management, and workflow software, which places it inside the administrative systems hospitals use to manage payments, coding, and day-to-day operations.

Much of the commercial momentum in healthcare AI is moving toward tools that reduce administrative burden and improve financial performance for providers. In March, healthcare AI spending reached $1.4 billion in 2025, nearly triple the level seen in 2024, with strong interest in claims management, payment disputes, and hospital administration.

Commure now works with more than 500 healthcare organizations across over 3,000 sites of care and serves more than 130 major health systems, including HCA Healthcare and Tenet Healthcare. The company also says its platform processes tens of billions of dollars in annual payments and that more than 85 percent of work on its revenue cycle platform is completed without human intervention. 

The valuation also reflects the company’s expansion beyond a single-product healthcare AI offering. After merging with Athelas and later acquiring Augmedix, Commure broadened its footprint across documentation, coding, revenue cycle management, and care operations, giving it a wider position in provider infrastructure than many healthcare AI firms focused on one application.